Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma.

Scognamiglio I, Di Martino MT, Campani V, Virgilio A, Galeone A, Gullà A, Gallo Cantafio ME, Misso G, Tagliaferri P, Tassone P, Caraglia M, De Rosa G.

Biomed Res Int. 2014;2014:217365. doi: 10.1155/2014/217365. Epub 2014 Feb 13.

PMID:
24683542
[PubMed - in process]
Free PMC Article
2.

In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma.

Di Martino MT, Campani V, Misso G, Gallo Cantafio ME, Gullà A, Foresta U, Guzzi PH, Castellano M, Grimaldi A, Gigantino V, Franco R, Lusa S, Cannataro M, Tagliaferri P, De Rosa G, Tassone P, Caraglia M.

PLoS One. 2014 Feb 27;9(2):e90005. doi: 10.1371/journal.pone.0090005. eCollection 2014.

PMID:
24587182
[PubMed - in process]
Free PMC Article
3.

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

Di Martino MT, Leone E, Amodio N, Foresta U, Lionetti M, Pitari MR, Cantafio ME, Gullà A, Conforti F, Morelli E, Tomaino V, Rossi M, Negrini M, Ferrarini M, Caraglia M, Shammas MA, Munshi NC, Anderson KC, Neri A, Tagliaferri P, Tassone P.

Clin Cancer Res. 2012 Nov 15;18(22):6260-70. doi: 10.1158/1078-0432.CCR-12-1708. Epub 2012 Oct 3.

PMID:
23035210
[PubMed - indexed for MEDLINE]
Free Article
4.

Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles.

Tivnan A, Orr WS, Gubala V, Nooney R, Williams DE, McDonagh C, Prenter S, Harvey H, Domingo-Fernández R, Bray IM, Piskareva O, Ng CY, Lode HN, Davidoff AM, Stallings RL.

PLoS One. 2012;7(5):e38129. doi: 10.1371/journal.pone.0038129. Epub 2012 May 25.

PMID:
22662276
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.

Nakatani F, Ferracin M, Manara MC, Ventura S, Del Monaco V, Ferrari S, Alberghini M, Grilli A, Knuutila S, Schaefer KL, Mattia G, Negrini M, Picci P, Serra M, Scotlandi K.

J Pathol. 2012 Apr;226(5):796-805. doi: 10.1002/path.3007.

PMID:
21960059
[PubMed - indexed for MEDLINE]
6.

MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.

de Antonellis P, Medaglia C, Cusanelli E, Andolfo I, Liguori L, De Vita G, Carotenuto M, Bello A, Formiggini F, Galeone A, De Rosa G, Virgilio A, Scognamiglio I, Sciro M, Basso G, Schulte JH, Cinalli G, Iolascon A, Zollo M.

PLoS One. 2011;6(9):e24584. doi: 10.1371/journal.pone.0024584. Epub 2011 Sep 12.

PMID:
21931765
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo.

Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q, Ma B.

PLoS One. 2012;7(3):e33778. doi: 10.1371/journal.pone.0033778. Epub 2012 Mar 21.

PMID:
22457788
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

miRNA-34a is associated with docetaxel resistance in human breast cancer cells.

Kastl L, Brown I, Schofield AC.

Breast Cancer Res Treat. 2012 Jan;131(2):445-54. doi: 10.1007/s10549-011-1424-3. Epub 2011 Mar 12.

PMID:
21399894
[PubMed - indexed for MEDLINE]
9.

MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.

Luan S, Sun L, Huang F.

Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007.

PMID:
20470934
[PubMed - indexed for MEDLINE]
10.

MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.

Pang RT, Leung CO, Lee CL, Lam KK, Ye TM, Chiu PC, Yeung WS.

BMC Cancer. 2013 Jan 18;13:25. doi: 10.1186/1471-2407-13-25.

PMID:
23327670
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.

Kumar B, Yadav A, Lang J, Teknos TN, Kumar P.

PLoS One. 2012;7(5):e37601. doi: 10.1371/journal.pone.0037601. Epub 2012 May 22.

PMID:
22629428
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.

Tivnan A, Tracey L, Buckley PG, Alcock LC, Davidoff AM, Stallings RL.

BMC Cancer. 2011 Jan 25;11:33. doi: 10.1186/1471-2407-11-33.

PMID:
21266077
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.

Bernardo BC, Gao XM, Tham YK, Kiriazis H, Winbanks CE, Ooi JY, Boey EJ, Obad S, Kauppinen S, Gregorevic P, Du XJ, Lin RC, McMullen JR.

PLoS One. 2014 Feb 27;9(2):e90337. doi: 10.1371/journal.pone.0090337. eCollection 2014.

PMID:
24587330
[PubMed - in process]
Free PMC Article
14.

Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery.

Tsuji T, Yoshitomi H, Usukura J.

Microscopy (Oxf). 2013 Jun;62(3):341-52. doi: 10.1093/jmicro/dfs080. Epub 2012 Nov 29.

PMID:
23204307
[PubMed - indexed for MEDLINE]
15.

Epigenetic inactivation of the miR-34a in hematological malignancies.

Chim CS, Wong KY, Qi Y, Loong F, Lam WL, Wong LG, Jin DY, Costello JF, Liang R.

Carcinogenesis. 2010 Apr;31(4):745-50. doi: 10.1093/carcin/bgq033. Epub 2010 Jan 29.

PMID:
20118199
[PubMed - indexed for MEDLINE]
Free Article
16.

microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.

Wang X, Dong K, Gao P, Long M, Lin F, Weng Y, Ouyang Y, Ren J, Zhang H.

Cancer Biother Radiopharm. 2013 Feb;28(1):45-50. doi: 10.1089/cbr.2012.1218. Epub 2012 Oct 4.

PMID:
23036084
[PubMed - indexed for MEDLINE]
17.

Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.

Lou W, Chen Q, Ma L, Liu J, Yang Z, Shen J, Cui Y, Bian XW, Qian C.

J Mol Med (Berl). 2013 Jun;91(6):715-25. doi: 10.1007/s00109-012-0985-x. Epub 2013 Jan 6.

PMID:
23292172
[PubMed - indexed for MEDLINE]
18.

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.

Asslaber D, Piñón JD, Seyfried I, Desch P, Stöcher M, Tinhofer I, Egle A, Merkel O, Greil R.

Blood. 2010 May 27;115(21):4191-7. doi: 10.1182/blood-2009-07-234823. Epub 2010 Jan 20.

PMID:
20089965
[PubMed - indexed for MEDLINE]
Free Article
19.

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.

Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M.

Biochem Biophys Res Commun. 2008 Dec 5;377(1):114-9. doi: 10.1016/j.bbrc.2008.09.086. Epub 2008 Oct 1.

PMID:
18834855
[PubMed - indexed for MEDLINE]
20.

MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines.

de Antonellis P, Liguori L, Falanga A, Carotenuto M, Ferrucci V, Andolfo I, Marinaro F, Scognamiglio I, Virgilio A, De Rosa G, Galeone A, Galdiero S, Zollo M.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):287-302. doi: 10.1007/s00210-013-0837-4. Epub 2013 Jan 26.

PMID:
23354452
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk